NASHUA, N.H., April 08, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced the appointment of Mark Koeniguer as Chief Commercial Officer (CCO), to lead the next phase of global growth for iCAD.
As CCO at iCAD, Koeniguer will assume responsibilities for revenue growth across North America and... Read more
PURCHASE, NY, April 08, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today introduced its next generation Cardiometabolic Health Program to improve population health and prevent the progression of diabetes, hypertension and obesity.
Building on the company’s industry-leading chronic condition management programs, the new offering is designed to support optimal cardiometabolic health for all populations. The program drives healthier... Read more
The partnership integrates advanced AI-driven analytics and clinical trial solutions, empowering biopharma companies to accelerate drug development and deliver targeted therapies faster. BETHESDA, Md. and BOSTON and ROLLE, Switzerland, April 8, 2025 /PRNewswire/ -- Precision for Medicine, a leading provider of drug development and commercialization services, today announced a strategic partnership with SOPHiA GENETICS to enhance its biomarker discovery and precision... Read more
SOMERSET, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, is pleased to announce its participation in the 15th Annual LD Micro Invitational at the Westin Grand Central Hotel in New York on April 9-10, 2025. The Company is scheduled to present on April 10, 2025 at 3:30 p.m. ET.
CareCloud’s... Read more
Total revenue grew 23% year-over-year driven by strong growth in both software and services
Maintains full-year revenue guidance of $90 to $93 million and adjusted diluted EPS of $1.07 to $1.20 RESEARCH TRIANGLE PARK, N.C. / Apr 03, 2025 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma... Read more
TORONTO, April 3, 2025 /PRNewswire/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered precision analytics in the pharmaceutical industry, today announced a global agreement with Worldwide Clinical Trials ("Worldwide"), a full-service, global contract research organization (CRO). This strategic partnership introduces... Read more
Focus on Inborn Errors of Immunity expands access to exome and genome testing for the known 200,000+ patients in the US 1 impacted by these conditions and opens new opportunities for GeneDx and biopharma partners to accelerate the path to treatment for patients GAITHERSBURG, Md. / Apr 03, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the commercial expansion into Inborn Errors of... Read more
Vancouver, British Columbia, Canada – TheNewswire - April 3, 2025 – PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) announces the resignation of Tammy Gillis as CFO of the Company. Ms. Gillis will continue to act as a financial consultant to the Company, and in particular, assist with completion of the year end audit process for the last fiscal year.
Current director Francisco Kent Carasquero will assume the role of CFO and remain a director... Read more
SOMERSET, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, today announced the acquisition of RevNu Medical Management (“RevNu”), an emerging audiology-focused revenue cycle management (“RCM”) company based in Westminster, California.
“We’ve spent years building trusted relationships... Read more
MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services
MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic... Read more
RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has released a new version of the Simcyp™ Simulator for physiologically-based pharmacokinetic (PBPK) modeling. Simcyp PBPK models describe and predict the behavior of drugs in different body tissues. The latest version includes numerous advancements to further support data-driven decision-making at every stage of development. &nb... Read more
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system. Integration with sponsors using Veeva's Clinical Platform... Read more
HEALWELL has acquired Auckland, New Zealand-based Orion Health Holdings Limited ("Orion Health"), a global healthcare intelligence platform providing subscription licenses and services to marquee public sector clients with data interoperability and healthcare navigation products.
Orion Health1 has approximately 400 employees with offices in 11 countries globally. Its software solutions currently support over 70 public and private sector customers representing 150 million... Read more
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a global leader in women’s health and family building, is expanding its support throughout the maternal health journey with the addition of doula services. Currently pregnancy, childbirth, and perinatal conditions represent one of the largest shares of employer health spend in the U.S. The addition of in-person and virtual doula services to Progyny’s comprehensive maternal offerings will further its... Read more
GE HealthCare has completed its acquisition of Sumitomo Chemical’s 50% stake in Nihon Medi-Physics (NMP), giving it full ownership.
As part of GE HealthCare, NMP, already a leading radiopharmaceutical company in Japan, is positioned to enhance patient access to next-generation radiopharmaceuticals that enable detection and diagnosis of disease
Kevin O’Neill, President & CEO of GE HealthCare’s Pharmaceutical Diagnostics segment, will also become President of... Read more
Fiscal 2024 revenue of $48.4 million
Adjusted EBITDA1 for Fiscal 2024 of $11.5 million, representing an Adjusted EBITDA Margin1 of 24%
Total Number of Clients2 of 841 as at December 31, 2024 TORONTO, March 31, 2025 /CNW/ - LifeSpeak Inc. ("LifeSpeak" or the "Company") (TSX: LSPK), the leading whole-person wellbeing solution for employers, health plans and other organizations, announced today its financial and operational results for the three and twelve... Read more
GE HealthCare’s Revolution Vibe CTi enables more facilities to elevate patient care by offering advanced cardiac imaging technology that helps deliver fast, accurate diagnoses, improve operational efficiency, and enhance patient outcomes.
Cardiovascular disease (CVD) is the leading cause of death and healthcare costs worldwide,ii with research projecting it could cause over 23 million deaths by 2030.iii The average number of cardiac computed tomography (CT) procedures... Read more
BEIJING, March 28, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.
Fourth Quarter 2024 Financial Highlights Total revenues were RMB369.2 million (US$50.6 million[1]), compared with... Read more
Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1 million
Total Revenue up 51% YoY to $20.6 million
Adjusted EBITDA ⁽²⁾ up 27% YoY to $5.0 million TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) announced today it has filed its Consolidated Financial Statements and Management's Discussion and Analysis report for the year ended December 31, 2024 with the Canadian securities... Read more
The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, is now available in select U.S. markets and has been granted traditional pass-through payment status by the U.S. Centers for Medicare and Medicaid. CHICAGO / Mar 27, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz... Read more
HEALWELL achieved record annual revenue from continuing operations of approximately $39 million in fiscal 2024, an increase of 433% compared to fiscal 2023. HEALWELL achieved record quarterly revenue from continuing operations of $15.2 million in Q4-2024, 692% higher than the $1.9 million generated in Q4-2023 and 11% higher than the $13.7 million generated in Q3-2024.
On December 16, 2024, HEALWELL announced the acquisition of Orion Health Holdings Limited ("Orion Health",... Read more
SOMERSET, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of healthcare technology and AI-powered revenue cycle management (RCM) solutions, today announced the expanded adoption of its services by Alpine Ear, Nose & Throat PC, a premier otolaryngology group based in Colorado. Following a successful RCM engagement, Alpine ENT has now implemented CareCloud FrontDesk Assist—a comprehensive front-office... Read more
Presentations include preclinical data on Wee1/Myt1 inhibitor SGR-3515 and SOS1 inhibitor SGR-4174 NEW YORK / Mar 25, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that new preclinical data on SGR-3515, its investigational Wee1/Myt1 inhibitor, and SGR-4174, its SOS1 inhibitor, will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25 - 30, 2025 in Chicago, IL.
The SGR-3515 presentation... Read more
Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace DALLAS, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, today announced that it has entered... Read more
Provides 2028 Targets for Revenue Growth, Margin Expansion, and Free Cash Flow ST. PAUL, Minn., March 20, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today hosts its 2025 Investor Day and will outline strategic priorities for the Company, its business segments, and its long-range plan (LRP) to drive growth and value creation.
"Solventum has tremendous potential, with attractive businesses, large and growing markets, and highly regarded brands. We have undertaken... Read more
The latest Invenia ABUS is designed to deliver optimal outcomes with its innovative, patient-friendly, and efficient AI-driven technology
Invenia ABUS Premium features new integrated Verisound AI and AI Assistant, which ensure faster and reproducible scanning and reading with extraordinary image quality
The non-invasive ultrasound technology, equipped with a novel Reverse Curve transducer and separate acquisition and reading capabilities, is built to enhance patient... Read more
Vancouver, British Columbia--(Newsfile Corp. - March 19, 2025) - Kovo+ Holdings Inc. (TSXV: KOVO) (formerly Kovo HealthTech Corporation) ("Kovo" or the "Company") is pleased to announce a best efforts private placement (the "LIFE Offering") of up to 28,000,000 common shares (the "Offered Shares") of the Company at a price of $0.05 per Offered Share for aggregate gross proceeds of up to $1,400,000.
Subject to compliance with applicable regulatory requirements and in... Read more
NASHUA, N.H., March 19, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) ("iCAD" or the "Company") a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the fourth quarter and full year ended December 31, 2024.
Fourth Quarter 2024 Highlights (Year-over-Year Performance): Total ARR (Annual Recurring Revenue) was $9.8&nb... Read more
Building on its 125-year legacy of medical imaging innovation and a 16-year relationship with NVIDIA, the two companies team up to advance AI-driven autonomous solutions designed to ease the growing burden on healthcare professionals. SAN JOSE, Calif. / Mar 18, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous... Read more
Highlights of the fiscal year include: Revenue of $1.20 billion, an increase of 20% compared to $999.6 million in FY24.
Net income of $96.7 million, an increase of 74% compared to $55.7 million in FY24, with non-GAAP net income of $277.3 million, an increase of 42% compared to $195.5 million in FY24.
Net income per diluted share of $1.09, an increase of 70% compared to $0.64 in FY24, with non-GAAP net income per diluted share of $3.12, an increase of 39% compared to... Read more
AltiX AI.i edition of Mac-Lab, CardioLab and ComboLab can enhance efficiency and precision care for multiple types of cardiac procedures CHICAGO / Mar 17, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex... Read more
Accomplished healthcare executives will work to drive growth, strengthen industry partnerships, and enhance pharmacy innovation at GoodRx SANTA MONICA, Calif. / Mar 17, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement, effective immediately.
Aaron will... Read more
Presentations to highlight how GeneDx is leveraging AI to drive both better patient care and scale GAITHERSBURG, Md. / Mar 13, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions will be presented at the 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting. GeneDx will showcase its leadership in genomic research and... Read more
GeneDx's Multiscore tool to be showcased at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting GAITHERSBURG, Md. / Mar 13, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision support tool designed to revolutionize genetic analysis by improving diagnostic efficiency, streamlining workflows, and enhancing clinical insights.... Read more
Returns to GAAP Profitability, Achieves Record Cash Flow, Resumes Dividends & Strengthens Balance Sheet SOMERSET, N.J., March 13, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the full year ended December 31, 2024. The Company’s strategic execution and AI-driven innovation have fueled a transformational turnaround, positioning... Read more
ALL-REMOTE COMPANY/WILMINGTON, Del. / Mar 12, 2025 / Business Wire / Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2025.
"We are pleased with our solid finish to fiscal 2025 and I am excited about the new products we have introduced over the past several quarters that improve medication adherence and the overall patient and provider experience," said CEO and Co-Founder... Read more
CHICAGO, March 12, 2025 (GLOBE NEWSWIRE) -- Cylinder, the leading virtual digestive health provider, today announced its partnership with Teladoc Health (NYSE: TDOC), the global leader in virtual care, to expand access to high-quality, personalized gastrointestinal care. Through this collaboration, Teladoc Health’s health plan and employer customers can easily provide members access to Cylinder's evidence-based digestive health platform, through streamlined administrative... Read more
ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an electronic test card and auto-reader for sterilization testing that eliminates the need for visual interpretation of results and manual documentation. In less than five seconds, the eBowie-Dick System's simple "pass" or "fail" digital display provides definitive test results and... Read more
Q4 revenue of $32.3 million, increasing 14% year-over-year
Q4 gross profit increased 23% year-over-year to $22.0 million with gross margin of 68%
Company generated revenue from 48 DAAP deals in 2024, up from 24 in 2023 WALTHAM, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients,... Read more
NASHVILLE, Tenn. / Mar 11, 2025 / Business Wire / HealthStream, Inc. (Nasdaq: HSTM), a leading healthcare technology platform company for workforce solutions, announced today that Charles E. Beard, Jr. has joined its Board of Directors and will serve as a member of the Audit Committee.
Mr. Beard brings a wealth of experience from his more than 30-year career, where he has held several executive-level positions. Until his recent retirement in December 2024, he served as Chief... Read more
NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the launch of its Parent and Child Well-being offering, designed to support and alleviate stress for working parents and caregivers. This offering extends Progyny’s ability to provide continuous support for parents from preconception through early childhood development, ultimately enhancing job satisfaction and... Read more
PURCHASE, NY, March 11, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the expansion of its connected care partnerships across new care categories including digestive health, centers of excellence, fertility and family building. In addition, recently announced technology integrations will empower Teladoc Health’s care providers and coaches to view members’ eligibility for these services and seamlessly refer them... Read more
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases INGELHEIM, Germany and PLEASANTON, Calif., March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first announced the One Medicine collaboration in March 2022. The unified... Read more
Revenue of $339.2 million for 2024 and $87.4 million in the fourth quarter
Net loss of $23.1 million for 2024 and $5.7 million in the fourth quarter
Adjusted EBITDA of $53.1 million for 2024 and $17.2 million in the fourth quarter MOBILE, Ala. / Mar 10, 2025 / Business Wire / TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the fourth quarter and year ended December 31, 2024.
2024 Operational Highlights Rebranded... Read more
MINNEAPOLIS, March 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet, an AI-powered Real World Data leader, has announced a collaboration with Datavant, a health data platform, to provide access to tokenized, purpose-built data for life sciences and medical research through Datavant’s health data ecosystem. Leveraging OneMedNet’s network of 31M patients, 121M+ clinical studies—EMR insights like images, ECGs, and notes—this collaboration enables life sciences companies to integrate... Read more
RESEARCH TRIANGLE PARK, N.C. / Mar 10, 2025 / Business Wire / Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in a fireside chat at the KeyBanc Capital Markets Virtual Healthcare Investor Forum on... Read more
WALTHAM, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced it has appointed Steve Silvestro as the Company’s new Chief Executive Officer, effective March 10, 2025.
Mr. Silvestro brings to OptimizeRx more than 20 years of experience in building and managing... Read more
NEW YORK / Mar 10, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025.
“Bridget has a proven track record of growing global software businesses, and we are pleased to welcome her to our Board,” said Ramy Farid, Ph.D., chief executive officer of Schrödinger. “Bridget’s leadership experience overseeing strategic initiatives at global technology companies,... Read more
BROOMFIELD, Colo., March 06, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today plans to expand Nociscan access across key markets in New York and New Jersey. The expansion plans build on previously established Nociscan... Read more
PURCHASE, NY, March 06, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC) today announced a pharmacy integration agreement with Eli Lilly’s LillyDirect pharmacy partner, Gifthealth, which will help streamline access to FDA-approved Zepbound® (tirzepatide) for Teladoc Health members enrolled in its Comprehensive Weight Care Program. This option will help members without insurance coverage for GLP-1s for obesity have more seamless access to affordable, safe, and effective... Read more
